Back to Results

PRF Technologies Ltd (PRFX)

PRF Technologies Ltd. is a clinical-stage specialty pharmaceutical company listed on NASDAQ under the symbol PRFX. The company focuses on reformulating established therapeutics, with an emphasis on providing extended post-surgical pain relief in Israel. Its lead program, PRF-110, is a viscous, clear oil-based solution designed to be applied directly into the surgical wound to deliver localized, extended post-operative analgesia. PRF-110 is being evaluated in Phase 3 clinical trials for pain treatment in patients undergoing bunionectomy and hernia repair procedures. The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel. It changed its name from PainReform Ltd. to PRF Technologies Ltd. in January 2026.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-PRFX
$1.03
35.4% Upside
Undervalued
Not available
Not available
Fair
0.0%
November 19, 2026
0.2x
85.7x
2.655 M
-8.227 M
1.5%
94.3%
-5.4
82.9%
Valuation • Fair Value

PRF Technologies Ltd (NASDAQ-PRFX) Fair Value by Valuation Model

Review the available estimates for PRF Technologies Ltd (NASDAQ-PRFX), including Comps Fair Value.

Primary Valuation Read

Fair Value

$1.03

Estimated upside of 35.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$1.03

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for PRF Technologies Ltd (NASDAQ-PRFX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for PRF Technologies Ltd (NASDAQ-PRFX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

31 K

Current operating scale indicator.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

-4.237 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review PRF Technologies Ltd (NASDAQ-PRFX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for PRF Technologies Ltd (NASDAQ-PRFX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Altman Z-Score

-5.4

Lower score that deserves closer risk review.

FCF / Net Income

82.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for PRF Technologies Ltd (NASDAQ-PRFX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for PRF Technologies Ltd (NASDAQ-PRFX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 19, 2026

Days to Earnings

13

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for PRF Technologies Ltd (NASDAQ-PRFX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

PRF Technologies Ltd (NASDAQ-PRFX) Stock Forecast & Technical Outlook

Review PRF Technologies Ltd (NASDAQ-PRFX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for PRF Technologies Ltd (NASDAQ-PRFX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for PRF Technologies Ltd (NASDAQ-PRFX) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for PRF Technologies Ltd (NASDAQ-PRFX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for PRF Technologies Ltd (NASDAQ-PRFX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for PRF Technologies Ltd (NASDAQ-PRFX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for PRF Technologies Ltd (NASDAQ-PRFX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, PRF Technologies Ltd (NASDAQ-PRFX) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

PRF Technologies Ltd (NASDAQ-PRFX) Stock FAQ

Data-supported answers about PRF Technologies Ltd (NASDAQ-PRFX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.03
Estimated upside 35.4%
Valuation Rating
Undervalued
Estimated upside of 35.4%
Financial Health
Fair
Current financial-health read

The current fair value estimate for PRF Technologies Ltd (NASDAQ-PRFX) is $1.03. This implies an estimated upside of 35.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 35.4% versus the current market price.

The current financial health read for PRF Technologies Ltd (NASDAQ-PRFX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for PRF Technologies Ltd (NASDAQ-PRFX) is November 19, 2026.

The latest available data indicates no current dividend yield for PRF Technologies Ltd (NASDAQ-PRFX).

The current market capitalization listed for PRF Technologies Ltd is 2.655 M.

The current enterprise value listed for PRF Technologies Ltd is -8.227 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for PRF Technologies Ltd is NASDAQ-PRFX, and the stock is listed on NASDAQ.

PRF Technologies Ltd (NASDAQ-PRFX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for PRF Technologies Ltd is 1.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for PRF Technologies Ltd is 94.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,215.6 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 655.6 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 362.2 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 310 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 179.5 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 170.3 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 129 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 113.6 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 69.723 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 48.75 B
HLN NYSE HALEON PLC ADR Fair Value Undervalued Market Cap 40.368 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 38.751 B
ZTS NYSE Zoetis Inc Fair Value Undervalued Market Cap 33.93 B
VTRS NASDAQ Viatris Inc Fair Value Fair Market Cap 21.789 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Undervalued Market Cap 14.59 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 11.996 B
ELAN NYSE Elanco Animal Health Fair Value Overvalued Market Cap 11.831 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Fair Market Cap 7.834 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Undervalued Market Cap 6.827 B